Research on COVID-19 Vaccination Technology Could Lead to HIV, Cancer Vaccines
New vaccines for HIV and seasonal flu are currently under development using the mRNA technique, along with vaccine therapies that could... (Source: Reuters: Health)
Source: Reuters: Health - January 23, 2021 Category: Consumer Health News Source Type: news

Covid Catch-up: Cancer missives, ‘menial’ tasks and vaccination leagues
A digest of this week’s daily updates of what our sources have been telling us about the progress of the pandemic. (Source: HSJ)
Source: HSJ - January 22, 2021 Category: UK Health Source Type: news

Massey researchers review geographic factors that affect HPV vaccination rates
(Virginia Commonwealth University) A team of researchers from VCU Massey Cancer Center conducted the first-ever systematic review of area-level data reported in the United States between 2006 and 2020 to determine how geography, neighborhoods and sociodemographic factors impact HPV vaccination rates among adolescents and young adults. The study was published inCancer Epidemiology, Biomarkers and Prevention. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 22, 2021 Category: Cancer & Oncology Source Type: news

NCCN shares new guidance principles for vaccinating people with cancer against COVID-19
(National Comprehensive Cancer Network) The National Comprehensive Cancer Network put out new guidance for COVID-19 vaccinations in people with cancer, based on available evidence plus consensus from top hematology and oncology experts with particular expertise in infectious diseases, vaccine development and delivery, and medical ethics. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 22, 2021 Category: Cancer & Oncology Source Type: news

Study: Vaccine protects against melanoma recurrence up to 4 years
A custom-made vaccine against melanoma still protects against advanced disease four years after cancer patients receive it, according to a study published Thursday by Nature Medicine. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 21, 2021 Category: Consumer Health News Source Type: news

Md. vaccine company raises another $16M for cancer programs after a strong 2020
The latest funding comes on top of $61.3 million in new funding the local biotech raised in April. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - January 18, 2021 Category: American Health Authors: Sara Gilgore Source Type: news

Md. vaccine company raises another $16M for cancer programs after a strong 2020
The latest funding comes on top of $61.3 million in new funding the local biotech raised in April. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 18, 2021 Category: Biotechnology Authors: Sara Gilgore Source Type: news

Safety of COVID-19 vaccines for patients with cancer and cancer survivors
As two new COVID-19 vaccines become more widely available, patients with cancer and cancer survivors may wonder if it's safe to be vaccinated. "Because cancer patients and survivors are at higher risk for severe effects from COVID-19 infection, we recommend they get vaccinated as soon as they can," says Robert McWilliams, M.D., a medical oncologist [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 15, 2021 Category: Databases & Libraries Source Type: news

Vaccine announcement spurs hospital questions in Florida
The chief medical officer of Moffitt Cancer Center said the Tampa-based hospital will exhaust this week its initial Covid-19 vaccine supply. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 13, 2021 Category: Pharmaceuticals Authors: Christine Sexton Source Type: news

Janssen to Highlight Commitment to Lung Cancer Science and Innovation with Eight Data Presentations at the International Association for the Study of Lung Cancer ’s 2020 World Conference on Lung Cancer
January 12, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that eight company-sponsored presentations, including two oral presentations, will be featured at the International Association for the Study of Lung Cancer’s (IASLC) 2020 World Conference on Lung Cancer (WCLC) Singapore taking place virtually January 28-31, 2021. The presentations include updated data from the Phase 1 CHRYSALIS study (NCT02609776) evaluating amivantamab in patients with NSCLC and EGFR exon 20 insertion mutations and two studies that characterize the high unmet need and lack of stand...
Source: Johnson and Johnson - January 13, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Concern Over Response to COVID-19 in Patients With Blood Cancers Concern Over Response to COVID-19 in Patients With Blood Cancers
Patients with solid tumors mount robust responses to COVID-19, but for those with blood cancers, responses are slower and milder, which may have implications for vaccination, say UK researchers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 12, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Strategic-collaboration-with-EnaraBio
Boehringer Ingelheim and Enara Bio Enter Strategic Collaboration and Licensing Agreement to Discover Novel Shared Antigens for Cancer Immunotherapies  Collaboration focuses on up to three types of lung and gastrointestinal (GI) cancersLatest in a series of strategic acquisitions and partnerships that strengthens Boehringer Ingelheim ’s position in the cancer vaccine and T-cell engager spacesAgreement and partnership with Boehringer Ingelheim provides additional validation of Enara Bio ’s  EDAPT™ platform and Dark Antigen™ discovery work and supports ongoing cell therapy based therapeutic a...
Source: Boehringer Ingelheim Corporate News - January 12, 2021 Category: Research Source Type: news

mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry
“No!” The doctor snapped. “Look at me!” I had been staring her in the eyes, as she had ordered, but when a doctor on my other side began jabbing me with a needle, I started to turn my head. “Don’t look at it,” the first doctor said. I obeyed. This was in early August in New Orleans, where I had signed up to be a participant in the clinical trial for the Pfizer-BioNTech COVID-19 vaccine. It was a blind study, which meant I was not supposed to know whether I had gotten the placebo or the real vaccine. I asked the doctor if I would really been able to tell by looking at the syringe. &...
Source: TIME: Health - January 11, 2021 Category: Consumer Health News Authors: Walter Isaacson Tags: Uncategorized COVID-19 feature Magazine Source Type: news

mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry
“No!” The doctor snapped. “Look at me!” I had been staring her in the eyes, as she had ordered, but when a doctor on my other side began jabbing me with a needle, I started to turn my head. “Don’t look at it,” the first doctor said. I obeyed. This was in early August in New Orleans, where I had signed up to be a participant in the clinical trial for the Pfizer-BioNTech COVID-19 vaccine. It was a blind study, which meant I was not supposed to know whether I had gotten the placebo or the real vaccine. I asked the doctor if I would really been able to tell by looking at the syringe. &...
Source: TIME: Science - January 11, 2021 Category: Science Authors: Walter Isaacson Tags: Uncategorized COVID-19 feature Magazine Source Type: news

Mayo Clinic Q & amp;A podcast: Screening can catch cervical cancer early
HPV is the most common cause of cervical cancer. And during January, Cervical Health Awareness Month, women are encouraged to receive the HPV vaccine. They also are encouraged to schedule a screening that can find precancerous conditions of the cervix. HPV infection and early cervical cancer don't cause noticeable symptoms, so regular screenings can detect changes in the cervix [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 11, 2021 Category: Databases & Libraries Source Type: news

Portuguese nurse dies after receiving coronavirus vaccine
(Natural News) A 41-year-old pediatric nurse from Portugal dropped dead not long after being injected with the first dose of Pfizer’s Wuhan coronavirus (COVID-19) vaccine. Reportedly in “perfect health” prior to getting jabbed, Sonia Azevedo, a mother who worked as a surgical assistant at the Instituto Portugues de Oncologia cancer hospital in Porto, was one... (Source: NaturalNews.com)
Source: NaturalNews.com - January 8, 2021 Category: Consumer Health News Source Type: news

The Petri Dish: Cancer drug fails trial and Moderna offers vaccine to board members
An oncology company is launching what could be one of the first IPOs of 2021, and Alkermes is getting a second shot with the FDA. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 31, 2020 Category: American Health Authors: Allison DeAngelis Source Type: news

First Reported U.S. Case of COVID-19 Variant Found in CO
By PATTY NIEBERG Associated Press/Report for America DENVER (AP) — The first reported U.S. case of the COVID-19 variant that’s been seen in the United Kingdom has been discovered in Colorado, Gov. Jared Polis announced Tuesday, adding urgency to efforts to vaccinate Americans. The variant was found in a man in his 20s who is in isolation southeast of Denver in Elbert County and has no travel history, state health officials said. Elbert County is a mainly rural area of rolling plains at the far edge of the Denver metro area that includes a portion of Interstate 70, the state’s main east-west highw...
Source: JEMS Patient Care - December 30, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Colorado Source Type: news

First Reported U.S. Case of COVID-19 Variant Found in CO
By PATTY NIEBERG Associated Press/Report for America DENVER (AP) — The first reported U.S. case of the COVID-19 variant that’s been seen in the United Kingdom has been discovered in Colorado, Gov. Jared Polis announced Tuesday, adding urgency to efforts to vaccinate Americans. The variant was found in a man in his 20s who is in isolation southeast of Denver in Elbert County and has no travel history, state health officials said. Elbert County is a mainly rural area of rolling plains at the far edge of the Denver metro area that includes a portion of Interstate 70, the state’s main east-west highw...
Source: JEMS Administration and Leadership - December 30, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Colorado Source Type: news

First Reported U.S. Case of COVID-19 Variant Found in CO
By PATTY NIEBERG Associated Press/Report for America DENVER (AP) — The first reported U.S. case of the COVID-19 variant that’s been seen in the United Kingdom has been discovered in Colorado, Gov. Jared Polis announced Tuesday, adding urgency to efforts to vaccinate Americans. The variant was found in a man in his 20s who is in isolation southeast of Denver in Elbert County and has no travel history, state health officials said. Elbert County is a mainly rural area of rolling plains at the far edge of the Denver metro area that includes a portion of Interstate 70, the state’s main east-west highw...
Source: JEMS Latest News - December 30, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Colorado Source Type: news

First Reported U.S. Case of COVID-19 Variant Found in CO
By PATTY NIEBERG Associated Press/Report for America DENVER (AP) — The first reported U.S. case of the COVID-19 variant that’s been seen in the United Kingdom has been discovered in Colorado, Gov. Jared Polis announced Tuesday, adding urgency to efforts to vaccinate Americans. The variant was found in a man in his 20s who is in isolation southeast of Denver in Elbert County and has no travel history, state health officials said. Elbert County is a mainly rural area of rolling plains at the far edge of the Denver metro area that includes a portion of Interstate 70, the state’s main east-west highw...
Source: JEMS: Journal of Emergency Medical Services News - December 30, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Colorado Source Type: news

First Reported U.S. Case of COVID-19 Variant Found in CO
By PATTY NIEBERG Associated Press/Report for America DENVER (AP) — The first reported U.S. case of the COVID-19 variant that’s been seen in the United Kingdom has been discovered in Colorado, Gov. Jared Polis announced Tuesday, adding urgency to efforts to vaccinate Americans. The variant was found in a man in his 20s who is in isolation southeast of Denver in Elbert County and has no travel history, state health officials said. Elbert County is a mainly rural area of rolling plains at the far edge of the Denver metro area that includes a portion of Interstate 70, the state’s main east-west highw...
Source: JEMS Operations - December 30, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Colorado Source Type: news

First Reported U.S. Case of COVID-19 Variant Found in CO
By PATTY NIEBERG Associated Press/Report for America DENVER (AP) — The first reported U.S. case of the COVID-19 variant that’s been seen in the United Kingdom has been discovered in Colorado, Gov. Jared Polis announced Tuesday, adding urgency to efforts to vaccinate Americans. The variant was found in a man in his 20s who is in isolation southeast of Denver in Elbert County and has no travel history, state health officials said. Elbert County is a mainly rural area of rolling plains at the far edge of the Denver metro area that includes a portion of Interstate 70, the state’s main east-west highw...
Source: JEMS Special Topics - December 30, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Colorado Source Type: news

Man With First Confirmed U.S. Case of Mutant COVID-19 Strain Has No Travel History
(DENVER) — The first reported U.S. case of the COVID-19 variant that’s been seen in the United Kingdom has been discovered in Colorado, Gov. Jared Polis announced Tuesday, adding urgency to efforts to vaccinate Americans. The variant was found in a man in his 20s who is in isolation southeast of Denver in Elbert County and has no travel history, state health officials said. Elbert County is a mainly rural area of rolling plains at the far edge of the Denver metro area that includes a portion of Interstate 70, the state’s main east-west highway. Colorado Politics reported there is a second suspected case o...
Source: TIME: Health - December 30, 2020 Category: Consumer Health News Authors: Patty Nieberg / AP and Report for America Tags: Uncategorized COVID-19 overnight wire Source Type: news

Man With First Confirmed U.S. Case of Fast-Spreading U.K. COVID-19 Strain Has No Travel History
DENVER — A Colorado National Guard member has the first reported U.S. case of a new and seemingly more contagious variant of the coronavirus that has set off alarm in Britain, while a second case is suspected in another Guard member, health officials said Wednesday. The two were sent on Dec. 23 to work at a nursing home struggling with an outbreak of the virus in a small town outside Denver, said Dr. Rachel Herlihy, the state’s epidemiologist. A state laboratory detected the cases after it began looking for signs of the variant after its spread was announced in England earlier this month, she said. Staff and re...
Source: TIME: Health - December 30, 2020 Category: Consumer Health News Authors: Colleen Slevin / AP Tags: Uncategorized COVID-19 overnight wire Source Type: news

Patients With Cancer a'High Priority' for COVID Vaccine Patients With Cancer a'High Priority' for COVID Vaccine
A position paper from the AACR calls for patients with cancer to have high priority access to COVID-19 vaccinations, given that they face a high risk of complications and death from the virus.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 29, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

City of Houston Gets First Doses of Moderna COVID-19 Vaccine
Dylan McGuinness Houston Chronicle (MCT) Dec. 28—A shipment of 6,000 doses of Moderna’s COVID-19 vaccine arrived in Houston on Monday, marking the city government’s first batch of the potentially life-saving shots. The arriving vaccines include 3,000 doses each for the Health Department and the Fire Department. Health workers and emergency medical technicians are first in line to get those vaccines, and they began getting the shots immediately Monday. Mayor Sylvester Turner and his top medical administrators toured the vaccination site. The mayor...
Source: JEMS Patient Care - December 29, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed COVID-19 Houston Texas Source Type: news

City of Houston Gets First Doses of Moderna COVID-19 Vaccine
Dylan McGuinness Houston Chronicle (MCT) Dec. 28—A shipment of 6,000 doses of Moderna’s COVID-19 vaccine arrived in Houston on Monday, marking the city government’s first batch of the potentially life-saving shots. The arriving vaccines include 3,000 doses each for the Health Department and the Fire Department. Health workers and emergency medical technicians are first in line to get those vaccines, and they began getting the shots immediately Monday. Mayor Sylvester Turner and his top medical administrators toured the vaccination site. The mayor...
Source: JEMS Administration and Leadership - December 29, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed COVID-19 Houston Texas Source Type: news

City of Houston Gets First Doses of Moderna COVID-19 Vaccine
Dylan McGuinness Houston Chronicle (MCT) Dec. 28—A shipment of 6,000 doses of Moderna’s COVID-19 vaccine arrived in Houston on Monday, marking the city government’s first batch of the potentially life-saving shots. The arriving vaccines include 3,000 doses each for the Health Department and the Fire Department. Health workers and emergency medical technicians are first in line to get those vaccines, and they began getting the shots immediately Monday. Mayor Sylvester Turner and his top medical administrators toured the vaccination site. The mayor...
Source: JEMS Latest News - December 29, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed COVID-19 Houston Texas Source Type: news

City of Houston Gets First Doses of Moderna COVID-19 Vaccine
Dylan McGuinness Houston Chronicle (MCT) Dec. 28—A shipment of 6,000 doses of Moderna’s COVID-19 vaccine arrived in Houston on Monday, marking the city government’s first batch of the potentially life-saving shots. The arriving vaccines include 3,000 doses each for the Health Department and the Fire Department. Health workers and emergency medical technicians are first in line to get those vaccines, and they began getting the shots immediately Monday. Mayor Sylvester Turner and his top medical administrators toured the vaccination site. The mayor...
Source: JEMS: Journal of Emergency Medical Services News - December 29, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed COVID-19 Houston Texas Source Type: news

City of Houston Gets First Doses of Moderna COVID-19 Vaccine
Dylan McGuinness Houston Chronicle (MCT) Dec. 28—A shipment of 6,000 doses of Moderna’s COVID-19 vaccine arrived in Houston on Monday, marking the city government’s first batch of the potentially life-saving shots. The arriving vaccines include 3,000 doses each for the Health Department and the Fire Department. Health workers and emergency medical technicians are first in line to get those vaccines, and they began getting the shots immediately Monday. Mayor Sylvester Turner and his top medical administrators toured the vaccination site. The mayor...
Source: JEMS Operations - December 29, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed COVID-19 Houston Texas Source Type: news

City of Houston Gets First Doses of Moderna COVID-19 Vaccine
Dylan McGuinness Houston Chronicle (MCT) Dec. 28—A shipment of 6,000 doses of Moderna’s COVID-19 vaccine arrived in Houston on Monday, marking the city government’s first batch of the potentially life-saving shots. The arriving vaccines include 3,000 doses each for the Health Department and the Fire Department. Health workers and emergency medical technicians are first in line to get those vaccines, and they began getting the shots immediately Monday. Mayor Sylvester Turner and his top medical administrators toured the vaccination site. The mayor...
Source: JEMS Special Topics - December 29, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: Coronavirus News News Feed COVID-19 Houston Texas Source Type: news

AIVITA Biomedical Closes $25 Million Financing Round
IRVINE, Calif., Dec. 29, 2020 -- (Healthcare Sales & Marketing Network) -- AIVITA Biomedical, Inc., a private biotechnology company developing personalized vaccines for the treatment of cancer and prevention of COVID-19, has closed its Series B-2 financin... Biopharmaceuticals, Oncology, Venture Capital AIVITA Biomedical, cancer vaccine, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 29, 2020 Category: Pharmaceuticals Source Type: news

Fueled by a History of Mistreatment, Black Americans Distrust the New COVID-19 Vaccines
When a COVID-19 vaccine becomes widely available to Americans, Brianna Clarke says she won’t be taking it. “I don’t trust the vaccine,” the 22-year-old says. “I think it’s too soon to have a vaccine.” Clarke, who lives in Willingboro, N.J., is among a significant number of Black Americans who are skeptical of the healthcare industry in general and, critically, the COVID-19 vaccines recently developed by pharmaceutical companies Pfizer-BioNTech and Moderna, more specifically. Over the past couple of weeks, the U.S. has averaged in the neighborhood of 200,000 new COVID-19 cases per d...
Source: TIME: Health - December 28, 2020 Category: Consumer Health News Authors: Dezimey Kum Tags: Uncategorized COVID-19 Source Type: news

Studies Find Having COVID-19 May Protect Against Reinfection
By MARILYNN MARCHIONE AP Chief Medical Writer Two new studies give encouraging evidence that having COVID-19 may offer some protection against future infections. Researchers found that people who made antibodies to the coronavirus were much less likely to test positive again for up to six months and maybe longer. The results bode well for vaccines, which provoke the immune system to make antibodies — substances that attach to a virus and help it be eliminated. Researchers found that people with antibodies from natural infections were “at much lower risk … on the order of the same kind of protect...
Source: JEMS Patient Care - December 26, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news

Studies Find Having COVID-19 May Protect Against Reinfection
By MARILYNN MARCHIONE AP Chief Medical Writer Two new studies give encouraging evidence that having COVID-19 may offer some protection against future infections. Researchers found that people who made antibodies to the coronavirus were much less likely to test positive again for up to six months and maybe longer. The results bode well for vaccines, which provoke the immune system to make antibodies — substances that attach to a virus and help it be eliminated. Researchers found that people with antibodies from natural infections were “at much lower risk … on the order of the same kind of protect...
Source: JEMS Administration and Leadership - December 26, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news

Studies Find Having COVID-19 May Protect Against Reinfection
By MARILYNN MARCHIONE AP Chief Medical Writer Two new studies give encouraging evidence that having COVID-19 may offer some protection against future infections. Researchers found that people who made antibodies to the coronavirus were much less likely to test positive again for up to six months and maybe longer. The results bode well for vaccines, which provoke the immune system to make antibodies — substances that attach to a virus and help it be eliminated. Researchers found that people with antibodies from natural infections were “at much lower risk … on the order of the same kind of protect...
Source: JEMS Latest News - December 26, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news

Studies Find Having COVID-19 May Protect Against Reinfection
By MARILYNN MARCHIONE AP Chief Medical Writer Two new studies give encouraging evidence that having COVID-19 may offer some protection against future infections. Researchers found that people who made antibodies to the coronavirus were much less likely to test positive again for up to six months and maybe longer. The results bode well for vaccines, which provoke the immune system to make antibodies — substances that attach to a virus and help it be eliminated. Researchers found that people with antibodies from natural infections were “at much lower risk … on the order of the same kind of protect...
Source: JEMS: Journal of Emergency Medical Services News - December 26, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news

Studies Find Having COVID-19 May Protect Against Reinfection
By MARILYNN MARCHIONE AP Chief Medical Writer Two new studies give encouraging evidence that having COVID-19 may offer some protection against future infections. Researchers found that people who made antibodies to the coronavirus were much less likely to test positive again for up to six months and maybe longer. The results bode well for vaccines, which provoke the immune system to make antibodies — substances that attach to a virus and help it be eliminated. Researchers found that people with antibodies from natural infections were “at much lower risk … on the order of the same kind of protect...
Source: JEMS Operations - December 26, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news

Studies Find Having COVID-19 May Protect Against Reinfection
By MARILYNN MARCHIONE AP Chief Medical Writer Two new studies give encouraging evidence that having COVID-19 may offer some protection against future infections. Researchers found that people who made antibodies to the coronavirus were much less likely to test positive again for up to six months and maybe longer. The results bode well for vaccines, which provoke the immune system to make antibodies — substances that attach to a virus and help it be eliminated. Researchers found that people with antibodies from natural infections were “at much lower risk … on the order of the same kind of protect...
Source: JEMS Special Topics - December 26, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news

Boston cancer doctor allergy to shellfish suffers severe allergic reaction receiving Moderna jab
A doctor experienced an allergic reaction after receiving the Moderna Covid-19 vaccine at Boston Medical Center on Christmas Eve. Dr.... (Source: Reuters: Health)
Source: Reuters: Health - December 26, 2020 Category: Consumer Health News Source Type: news

Experts Call For People With Cancer To Receive Priority Access To Covid-19 Vaccines
People with cancer are twice as likely to die from Covid-19. Now, experts are calling for people with cancer to be given priority for Covid-19 vaccines. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 22, 2020 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma & Source Type: news

U.S. Deaths in 2020 Top Three Million
By MIKE STOBBE AP Medical Writer NEW YORK (AP) — This is the deadliest year in U.S. history, with deaths expected to top 3 million for the first time — due mainly to the coronavirus pandemic. Final mortality data for this year will not be available for months. But preliminary numbers suggest that the United States is on track to see more than 3.2 million deaths this year, or at least 400,000 more than in 2019. U.S. deaths increase most years, so some annual rise in fatalities is expected. But the 2020 numbers amount to a jump of about 15%, and could go higher once all the deaths from this month are cou...
Source: JEMS Patient Care - December 22, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus EMS Hospital Prehospital Source Type: news

U.S. Deaths in 2020 Top Three Million
By MIKE STOBBE AP Medical Writer NEW YORK (AP) — This is the deadliest year in U.S. history, with deaths expected to top 3 million for the first time — due mainly to the coronavirus pandemic. Final mortality data for this year will not be available for months. But preliminary numbers suggest that the United States is on track to see more than 3.2 million deaths this year, or at least 400,000 more than in 2019. U.S. deaths increase most years, so some annual rise in fatalities is expected. But the 2020 numbers amount to a jump of about 15%, and could go higher once all the deaths from this month are cou...
Source: JEMS Administration and Leadership - December 22, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus EMS Hospital Prehospital Source Type: news

U.S. Deaths in 2020 Top Three Million
By MIKE STOBBE AP Medical Writer NEW YORK (AP) — This is the deadliest year in U.S. history, with deaths expected to top 3 million for the first time — due mainly to the coronavirus pandemic. Final mortality data for this year will not be available for months. But preliminary numbers suggest that the United States is on track to see more than 3.2 million deaths this year, or at least 400,000 more than in 2019. U.S. deaths increase most years, so some annual rise in fatalities is expected. But the 2020 numbers amount to a jump of about 15%, and could go higher once all the deaths from this month are cou...
Source: JEMS Latest News - December 22, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus EMS Hospital Prehospital Source Type: news

U.S. Deaths in 2020 Top Three Million
By MIKE STOBBE AP Medical Writer NEW YORK (AP) — This is the deadliest year in U.S. history, with deaths expected to top 3 million for the first time — due mainly to the coronavirus pandemic. Final mortality data for this year will not be available for months. But preliminary numbers suggest that the United States is on track to see more than 3.2 million deaths this year, or at least 400,000 more than in 2019. U.S. deaths increase most years, so some annual rise in fatalities is expected. But the 2020 numbers amount to a jump of about 15%, and could go higher once all the deaths from this month are cou...
Source: JEMS: Journal of Emergency Medical Services News - December 22, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus EMS Hospital Prehospital Source Type: news

U.S. Deaths in 2020 Top Three Million
By MIKE STOBBE AP Medical Writer NEW YORK (AP) — This is the deadliest year in U.S. history, with deaths expected to top 3 million for the first time — due mainly to the coronavirus pandemic. Final mortality data for this year will not be available for months. But preliminary numbers suggest that the United States is on track to see more than 3.2 million deaths this year, or at least 400,000 more than in 2019. U.S. deaths increase most years, so some annual rise in fatalities is expected. But the 2020 numbers amount to a jump of about 15%, and could go higher once all the deaths from this month are cou...
Source: JEMS Operations - December 22, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus EMS Hospital Prehospital Source Type: news

U.S. Deaths in 2020 Top Three Million
By MIKE STOBBE AP Medical Writer NEW YORK (AP) — This is the deadliest year in U.S. history, with deaths expected to top 3 million for the first time — due mainly to the coronavirus pandemic. Final mortality data for this year will not be available for months. But preliminary numbers suggest that the United States is on track to see more than 3.2 million deaths this year, or at least 400,000 more than in 2019. U.S. deaths increase most years, so some annual rise in fatalities is expected. But the 2020 numbers amount to a jump of about 15%, and could go higher once all the deaths from this month are cou...
Source: JEMS Special Topics - December 22, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus EMS Hospital Prehospital Source Type: news